We’ve previously found that health technology funding is on an overall upward trend. Now we are taking a closer look on our health technology research platform to compare funding by category. Our analysis reveals two observations:
- The Genomics category leads the sector in Q2 funding
- The Digital Medical Devices category leads the sector in all-time funding
We’ll highlight these observations with some graphics and discussions below.
The Genomics Category Leads Health Technology In Q2 Funding
To start off, let’s review the amount of funding raised this quarter by each category within health technology.
The above graphic highlights that the Genomics category leads the sector in Q2 funding with just under $1B. Its funding is 1.4 times the funding of the next category, Digital Medical Devices at $700M.
Genomics companies utilize human genome data for analytics, prevention, and treatment. Some example companies in this category are 23andMe, Helix, and Counsyl.
Let’s now investigate how these categories’ funding compare with each other historically.
The Digital Medical Devices Category Leads the Sector in All-Time Funding
The graph below shows the all-time funding for different health technology categories. The Q2 funding and growth rates of these categories are also highlighted.
As the bar graph indicates, the Digital Medical Devices category leads the sector in total funding at almost $14B. The Genomics category follows in a close second place with an all-time funding of $13.6B. These two categories’ funding are more than twice the funding of the next category, IoT Fitness at $6.6B.
Digital Medical Device companies build IT-enabled medical and diagnostic devices for doctors. These devices include detection equipment, monitoring equipment, and surgical tools. Some example companies are Signostics, MediBeacon, Stimwave, and AliveCor.
In summary, it’s clear that the Genomics and Digital Medical Devices categories are leading the sector in funding. Let’s see how the the rest of 2018 shapes up for health technology!